[CAS NO. 204981-48-6]  CP-195543

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [204981-48-6]

Catalog
AS1021240
Brand
Arctom Scientific
CAS
204981-48-6

DESCRIPTION [204981-48-6]

Overview

MDL-
Molecular Weight428.40
Molecular FormulaC24H19F3O4
SMILESO=C(O)C1=CC=C(C(F)(F)F)C=C1C2=CC=C3[C@H](O)[C@@H](CC4=CC=CC=C4)COC3=C2

For research use only. We do not sell to patients.

Summary

CP-195543 is a potent, selective and orally active leukotriene B4 (LTB4) receptor antagonist with IC 50 s of 6.8, 37.0 nM for human neutrophils and murine spleen membranes, respectively. CP-195543 blocks CD11b up-regulation. CP-195543 inhibits LTB4-mediated neutrophil infiltration [1] .


IC50 & Target

LTB 4


In Vitro

CP-195543 inhibits human and mouse neu-trophil chemotaxis mediated by LTB4 with IC 50 values of 2.4 nM, 7.5 nM, respectively [1] .
CP-195543 (0.1 nM-10 µM; 60 min) blocks CD11b up-regulation on human neutrophils (HN) and murine neutrophils with IC 50 s of 270, 420 nM for human monocytes and eosinophils, respectively [1] .

MCE has not independently confirmed the accuracy of these methods. They are for reference only.


In Vivo

CP-195543 (0.01, 0.1, 1, 10 mg/kg for guinea pig; 0.01, 0.1, 1, 10, 100 mg/kg for mice; P.o.; 1 h before injection of LTB4) inhibits LTB4-mediated neutrophil infiltration in guinea pigskin in a dose-dependent manner [1] .

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Guinea pig (Injection of LTB4 10, 30, 100 ng/site; injected intradermally) [1]
Dosage: 0.01, 0.1, 1, 10 mg/kg
Administration: P.o.; 1 h before injection of LTB4
Result: Inhibited LTB4-mediated neutrophil infiltration in guinea pigskin in a dose-dependent manner.
Animal Model: Mice (Injection of LTB4 100 ng/site; injected intradermally) [1]
Dosage: 0.01, 0.1, 1, 10, 100 mg/kg
Administration: P.o.; 1 h before injection of LTB4
Result: Inhibited LTB4-mediated neutrophil infiltration in guinea pigskin in a dose-dependent manner.

Shipping

Room temperature in continental US; may vary elsewhere.


Storage

Please store the product under the recommended conditions in the Certificate of Analysis.